Back to search

Article

Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis

2019-12-10

Abstract excerpt

<h4>Background: </h4> Liposomal amphotericin B (AmBisome®) as a treatment modality for visceral leishmaniasis (VL) has had significant impact on patient care in some but not all regions where VL is endemic.  As the mode of action of AmBisome® in vivo is poorly understood, we compared the tissue-specific transcriptome in drug-treated vs untreated mice with experimental VL.    <h4>Methods: </h4>:  BALB/c mice infe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
829d198e-03df-5806-94c6-2f751f231172
DOI
10.12688/wellcomeopenres.15606.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasisDOI 10.12688/wellcomeopenres.15606.1
Select a neighboring publication to make it the new centre.